• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Ketamine Treatment May Be Safe For Children With Depression

June 6, 2023 by Deborah Bloomfield

Ketamine is emerging as a promising treatment for depression in adults, with some studies indicating that the drug alleviates mental suffering in as little as 24 hours. Understandably, however, there are concerns over the pediatric use of the drug, although a new review study suggests that repeated doses of ketamine may in fact be safe for kids.

Despite its connotations as an illicit party drug, ketamine has been administered to children in medical settings for many decades. According to the study authors, “ketamine has an outstanding safety profile in children when used as a single-dose treatment, hence its extensive global use for analgesia, anesthesia and sedation.”

Advertisement

However, while the drug has shown huge potential as a treatment for depression, its therapeutic effects are transient, which means repeated doses are necessary. “Thus, there are concerns about the safety of long-term administration of ketamine apropos of the development of tolerance and whether medicinal ketamine use could serve as a gateway into illicit drug use,” write the researchers. “As such, the expansion of studies into pediatric populations has been limited.”

To investigate the safety of giving repeated doses to children, the study authors conducted a systematic review of the existing research on this topic. In total, they identified 87 cases of kids being administered ketamine over extended periods, with the highest number of doses received by a single child being 42.

Overall, they identified no serious adverse reactions. There was also no evidence of children requiring higher doses over time, indicating that none of the kids developed tolerance to the drug.

“The longest follow-up period was 6 months,” reveal the researchers. “There were no long-term consequences (including neurocognitive) reported within this time frame.”

Advertisement

Surprisingly, the study authors found that some children were even able to tolerate doses that were significantly higher than those usually administered to adults. Odd as this may seem, there is evidence to suggest that kids metabolize the drug faster than grown-ups, so such a finding is perhaps less unexpected than one would think.

Ketamine is also associated with a series of alarming side-effects that are collectively known as emergence phenomena. Resembling schizophrenia, these phenomena include delirium and hallucinations, and have been reported to occur in up to 55 percent of adult users.

However, the study authors reveal that “emergence phenomena were not reported in any of the patients in this study, which is consistent with previous reports that this frightening symptom is less common in children than adults.”

Despite the apparent safety of repeated ketamine use, though, some children did experience side-effects. The most common of these was dissociation, which accounted for 48 percent of all adverse reactions. Other negative effects included headaches and nausea, though all such reactions were mild and resolved themselves without the need for medical intervention.

Advertisement

Overall, the researchers say that their findings support the development of large-scale clinical trials into the use of repeated ketamine doses as a treatment for children with depression.

The study is published in the Journal of Psychopharmacology.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Global reinsurance rates to keep rising next year – Moody’s
  2. Italy reports 26 coronavirus deaths on Sunday, 3,838 new cases
  3. Police Claim Woman Attacked Them With Angry Bees During An Eviction
  4. Why Do Airplane Window Shades Have To Be Up During Takeoff And Landing?

Source Link: Ketamine Treatment May Be Safe For Children With Depression

Filed Under: News

Primary Sidebar

  • The Pinky Toe Has A Purpose And Most People Are Just Finding Out
  • What Is This Massive Heat-Emitting Mass Discovered Beneath The Moon’s Surface?
  • The Man Who Fell From Space: These Are The Last Words Of Cosmonaut Vladimir Komarov
  • How Long Can A Bird Can Fly Without Landing?
  • Earliest Evidence Of Making Fire Has Been Discovered, X-Rays Of 3I/ATLAS Reveal Signature Unseen In Other Interstellar Objects, And Much More This Week
  • Could This Weirdly Moving Comet Have Been The Real “Star Of Bethlehem”?
  • How Monogamous Are Humans Vs. Other Mammals? Somewhere Between Beavers And Meerkats, Apparently
  • A 4,900-Year-Old Tree Called Prometheus Was Once The World’s Oldest. Then, A Scientist Cut It Down
  • Descartes Thought The Pineal Gland Was “The Seat Of The Soul” – And Some People Still Do
  • Want To Know What The Last 2 Minutes Before Being Swallowed By A Volcanic Eruption Look Like? Now You Can
  • The Three Norths Are Moving On: A Once-In-A-Lifetime Alignment Shifts This Weekend
  • Spectacular Photo Captures Two Rare Atmospheric Phenomena At The Same Time
  • How America’s Aerospace Defense Came To Track Santa Claus For 70 Years
  • 3200 Phaethon: Parent Body Of Geminids Meteor Shower Is One Of The Strangest Objects We Know Of
  • Does Sleeping On A Problem Actually Help? Yes – It’s Science-Approved
  • Scientists Find A “Unique Group” Of Polar Bears Evolving To Survive The Modern World
  • Politics May Have Just Killed Our Chances To See A Tom Cruise Movie Actually Shot In Space
  • Why Is The Head On Beer Often White, When Beer Itself Isn’t?
  • Fabric Painted With Dye Made From Bacteria Could Protect Astronauts From Radiation On Moon
  • There Used To Be 27 Letters In The English Alphabet, Until One Mysteriously Vanished
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version